While standard models suffer from context rot as data grows, MIT’s new Recursive Language Model (RLM) framework treats ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Detroit Lions safety Brian Branch, who was carted to the locker room in the waning moments of a 44-30 win over the Dallas Cowboys on Thursday night, has a torn Achilles that will end his season, The ...

Detroit Lions safety Brian Branch is expected to miss the remainder of the season after tests confirmed he suffered a torn Achilles during Thursday night's 44-30 win over the Dallas Cowboys, according ...

Read full article: Parents call for more safety resources after ‘near miss’ at Ann Arbor elementary school Read full article: Snow targets Metro Detroit’s Wednesday morning commute: What to expect ...

Lions safety Brian Branch left Thursday night’s win over the Cowboys with an injury that may bring his season to an end. NFL Media reports that Branch is feared to have suffered an Achilles injury. He ...

Last year, it was the defensive line. This year, it’s the secondary. The Detroit Lions lost another starting defensive back to injury Thursday, Dec. 4, when Brian Branch hobbled off the field with an ...

A loss to NFC North rival Green Bay on Thanksgiving put the Detroit Lions out of playoff seeding. A week later, the Lions bounced back with a crucial win over the Dallas Cowboys. That win may have ...

Top high school junior class prospect reclassifies to become eligible for 2027 NBA Draft. Krysten Peek, for NBA.com Top prospect Bruce Branch III reclassifies to the class of 2026 live on NBA TV and ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...